Disparities in productivity levels across firms within manufacturing sectors is wider in India than in China, Mexico, Russia and Korea, said Mark Dutz, World Bank Senior Economist and editor of the report -- Unleashing India's Innovation.
PhD, MPhil, MS Programmes at Jawaharlal Nehru Tech Univ, Hyderabad
B S Yediyurappa, deputy chief minister designate of the new Bharatiya Janata Party-Janata Dal (Secular) coalition government to be sworn-in in Karnataka on February 3, Sunday said the government would formulate a Common Minimum Programme.
Biotechnology major Biocon has got the Drug and Controller General of India approval for marketing its BIOMAb EGFR in the Indian market. This is a proprietary product of Biocon, which will be used in treating head and neck cancers.
Indian scientists who wrote to the PM last week are not entirely rejecting GMOs but instead asking for caution and further testing to establish their safety.
But, majority might be left out, as only those investing in entities recognised by the government could qualify
Matrix said the acquisition of a controlling stake of 55% was aimed at adding to its technology and manufacturing strengths and to utilise the market potential of the fermentation technology-based products of Concord.
Alert: A PhD/MS programme at the Indian Institute of Technology Madras, beginning January 2005.
India's biotechnology major Biocon Ltd, is all set to make its way to Pakistan's pharmaceutical market by 2008 with its oncology drug BIOMAb EGFR.
Nicholas Piramal India has acquired UK-based Avecia Pharmaceuticals for £9.5 million.
The rapidly progressing Indian pharma industry, assisted by a strong research and development base, skilled manpower, low-cost base and manufacturing excellence has provided the industry with the right platform to move towards achieving its goal.
Trials on genetically modified food or non-food crops would be carried out only after the settlement of a case pending before the Supreme Court, a senior official with the department of biotechnology said on Tuesday.
Nobex, after running out of money last year, had filed for bankruptcy.
Tiens Group is treating more than half of its 12,000 employees to a four-day holiday in France.
Inviting Canadian entrepreneurs, India has said the country is fast emerging as an attractive destination for investors in various sectors especially in energy, information technology and biotechnology.
Total investment in this sector is expected to cross Rs 200 crore
Yemen is ranked the worst (153rd), while Iraq is 152nd and Pakistan 151st.
Bangalore-based company aims to raise around Rs 300 crore
Exports revenue of Indian biotech industry grew by 47 per cent during 2006-07 at Rs 4,937 crore (USD 1.2 billion), even as the total revenue, including the domestic figures, stood at Rs 8,541 crore (Rs 85.41 billion).
The Norwegian side expressed interest in joining the project and sought details from the Indian side.
Career counsellor Srividya from YoungBuzz tells you how.
Cadila Pharmaceuticals Ltd on Monday said it would market anti-cancer drugs GCS
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances